All Immunology articles – Page 18
-
CareersThe Kulkarni Lab
The Kulkarni Lab works to determine how locally derived complement proteins in the lung can be harnessed to reduce the burden of end-stage lung disease.
-
NewsClinicians ID severe form of mpox with high mortality in people with advanced HIV
An international collaboration of clinicians has identified a severe, necrotising form of mpox with a high mortality in immunosuppressed people living with HIV.
-
NewsMicrobiota from mum regulates lung immunity in newborns
Researchers have discovered that a type of white blood cells, the γδ T cells, influences the transfer of maternal microbiota during birth and nursing, and impacts the lung immune response in newborns.
-
NewsCellular evidence reveals why men are at higher risk from COVID-19
Researchers from Osaka University provide cellular evidence for the observed differences between the response to COVID-19 infection in male and female patients.
-
NewsViruses that kill cancer cells show promise for triple-negative breast cancer when combined with chemo
Researchers have shared positive results from a phase 2 clinical trial of an oncolytic virus combined with standard chemotherapy in patients with early stage triple-negative breast cancer.
-
NewsStudy IDs bacterial weapons that could be harnessed to treat human disease
The discovery of ancient immune-fighting machinery in human cells that is derived from bacteria paves the way toward more ‘CRISPR’-like technologies, researchers say.
-
NewsME linked to changes in the gut microbiome and metabolites
Two studies have found that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is associated with reduced levels in the gastrointestinal microbiome of microbes known to produce the fatty acid butyrate, disruptions that could explain in part how the immune system becomes disrupted in people with ME/CFS.
-
NewsSilent flagellin delivers insights into how gut bacteria evade the immune system
Researchers from the Max Planck Institute for Biology Tübingen have identified a new type of flagellin in the human gut, termed ‘silent flagellin’, that binds to the immune receptor Toll-like receptor 5 without inducing a pro-inflammatory response. Their work addresses the long-standing question of how benign gut microbes evade the ...
-
NewsCannabis shows potential as weapon in the fight against COVID-19
Cannabis could become an important weapon in the battle against Covid-19, with a new review suggesting both cannabinoids and terpenes show great promise in lab research, due to their antiviral qualities.
-
NewsGut bacteria can impact immune cells that damage brain tissue
Gut bacteria affect the behaviour of immune cells throughout the body, including ones in the brain that can damage brain tissue and exacerbate neurodegeneration in conditions such as Alzheimer’s disease, according to new research.
-
NewsThree compounds from sea sponge and marine bacteria offer Covid-blocking powers
University of British Columbia researchers have identified three compounds that prevent COVID-19 infection in human cells, derived from natural sources including a BC sea sponge.
-
NewsPoor gut health may drive multiple sclerosis — but better diet may ease it
Researchers have traced a previously observed link between microscopic organisms in the digestive tract — collectively known as the gut microbiome — and multiple sclerosis (MS).
-
NewsGut microbiome responds to nanomaterial graphene oxide as if it were a parasite
The nanomaterial graphene oxide—which is used in everything from electronics to sensors for biomolecules—can indirectly affect the immune system via the gut microbiome.
-
NewsImmune response discovery solves mystery of why colds are more common when it’s cold
Scientists say a newly discovered immune response inside the nose is suppressed by colder temperatures, offering evidence for why colds, flu and COVID-19 are more common in cooler months.
-
NewsCOVID-19 reanimates latent viruses in cells – particularly in ME patients
Researchers have found that COVID-19 reactivates viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.
-
NewsGut bacterium could trigger rheumatoid arthritis in those at risk
Researchers at the University of Colorado School of Medicine have discovered that a unique bacterium found in the gut could be responsible for triggering rheumatoid arthritis (RA) in people already at risk for the autoimmune disease.
-
NewsIntranasal COVID vaccine works against variants in animals
Researchers have developed an intranasal vaccine against Covid-19 that can fight off the original virus and two variants in hamsters.
-
NewsKeele University launches new course in microbiology and immunology
Students will learn about the microscopic science of disease prevention, and stopping pandemics like Covid-19 in their tracks, on a new degree programme in Keele University’s School of Life Sciences.
-
FeaturesThe life and times of Sir Henry Wellcome
Wellcome was committed to high-quality science and founded other laboratories to join the WPRL, including the Wellcome Tropical Research Laboratory in Khartoum.
-
FeaturesMitigate or suppress—coming to grips with the COVID-19 pandemic
In the absence of an efficient vaccine, the control of the COVID-19 pandemic currently relies on non-pharmaceutical interventions.